DPP10-AS2

Across TCGA pan-cancer cohorts, DPP10-AS2 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated DPP10-AS2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DPP10-AS2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DPP10-AS2 expression acts as an unfavorable survival marker.

KIRC and KIRP are the cancer types where DPP10-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
KIRP	OS	Tertile	All	0.250	0.710	.020	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DPP10-AS2–KIRC (DFS)

Open the KIRC breakdown →